Science Publications

Sign Up
Sign In
Submit
Current Research in Public Health
Cite This Article Share Download PDF XML
  1. Home
  2. Journals
  3. Current Research in Public Health
  4. Archive
  5. Volume 2, Issue 2, 2022
  6. Article
Mini Review Open Access March 26, 2022

Role of Ivermectin in Management of COVID-19

Areej Mohamed Abdelhady Ahmed Helaly 1, Ghada Essam El-Din Amin 1, 2, Salwa Mostafa Mohammad Abdel Rahman 1, 3 and Mohamed Farouk Allam 1, 4,*
1
Department of Family Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt
2
Department of Community, Environmental and Occupational Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt
3
Department of Anesthesia, Intensive Care and Pain Management, Faculty of Medicine, Ain Shams University, Cairo, Egypt
4
Department of Preventive Medicine and Public Health, School of Medicine, University of Cordoba, Cordoba 14004, Spain
Publihed in: Current Research in Public Health (Volume 2, Issue 2, 2022)
Page(s): 36-37
DOI: 10.31586/gjeid.2022.238
Received
January 21, 2022
Revised
March 16, 2022
Accepted
March 24, 2022
Published
March 26, 2022
Keywords
Coronavirus; COVID-19; Ivermectin; Management; Review
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright: Copyright © The Author(s), 2022. Published by Scientific Publications
Article metrics
Views
693
Downloads
200

Cite This Article

APA Style
Helaly, A. M. A. A. , Helaly, A. M. A. A. Amin, G. E. E. , Amin, G. E. E. Rahman, S. M. M. A. , & Rahman, S. M. M. A. (2022). Role of Ivermectin in Management of COVID-19. Current Research in Public Health, 2(2), 36-37. https://doi.org/10.31586/gjeid.2022.238
ACS Style
Helaly, A. M. A. A. ; Helaly, A. M. A. A. Amin, G. E. E. ; Amin, G. E. E. Rahman, S. M. M. A. ; Rahman, S. M. M. A. Role of Ivermectin in Management of COVID-19. Current Research in Public Health 2022 2(2), 36-37. https://doi.org/10.31586/gjeid.2022.238
Chicago/Turabian Style
Helaly, Areej Mohamed Abdelhady Ahmed, Areej Mohamed Abdelhady Ahmed Helaly. Ghada Essam El-Din Amin, Ghada Essam El-Din Amin. Salwa Mostafa Mohammad Abdel Rahman, and Salwa Mostafa Mohammad Abdel Rahman. 2022. "Role of Ivermectin in Management of COVID-19". Current Research in Public Health 2, no. 2: 36-37. https://doi.org/10.31586/gjeid.2022.238
AMA Style
Helaly AMAA, Helaly AMAAAmin GEE, Amin GEERahman SMMA, Rahman SMMA. Role of Ivermectin in Management of COVID-19. Current Research in Public Health. 2022; 2(2):36-37. https://doi.org/10.31586/gjeid.2022.238 
@Article{crph238,
AUTHOR = {Helaly, Areej Mohamed Abdelhady Ahmed and Amin, Ghada Essam El-Din and Rahman, Salwa Mostafa Mohammad Abdel and Allam, Mohamed Farouk},
TITLE = {Role of Ivermectin in Management of COVID-19},
JOURNAL = {Current Research in Public Health},
VOLUME = {2},
YEAR = {2022},
NUMBER = {2},
PAGES = {36-37},
URL = {https://www.scipublications.com/journal/index.php/GJEID/article/view/238},
ISSN = {2831-5162},
DOI = {10.31586/gjeid.2022.238},
ABSTRACT = {The pandemic corona virus disease 19 (COVID-19), caused by (SARS-CoV-2) a single stranded-RNA virus, has been spread rapidly worldwide with high rate of morbidity and mortality. Few months after the spread of the pandemic, few medications have proven to be efficient in human clinical trials. Several antiviral drugs have been used outside the scope of their initial medical use, such as lopinavir, hydroxychloroquine or azithromycin. Recent researches were done to show the efficacy of ivermectin in reducing SARS-CoV-2 viral RNA within 2 days. The use of ivermectin in in vitro studies has proven its efficacy against Corona virus. Based on the potency of ivermectin in in vitro studies, various clinical trials including patients infected with COVID-19 have been started; most of them have not been completed yet. Since the way how the virus infects the cells in vitro and in vivo is different, a decisive comment about how the ivermectin could exactly be beneficial to the patients has not been proven yet. Nevertheless, if ivermectin is compared to the other therapeutic treatments available for COVID-19 management, ivermectin has proved to have leverage over them. New randomized controlled clinical trials to assess the effectiveness of ivermectin the management of COVID-19 are strongly and urgently needed.},
}
%0 Journal Article
%A Helaly, Areej Mohamed Abdelhady Ahmed
%A Amin, Ghada Essam El-Din
%A Rahman, Salwa Mostafa Mohammad Abdel
%A Allam, Mohamed Farouk
%D 2022
%J Current Research in Public Health

%@ 2831-5162
%V 2
%N 2
%P 36-37

%T Role of Ivermectin in Management of COVID-19
%M doi:10.31586/gjeid.2022.238
%U https://www.scipublications.com/journal/index.php/GJEID/article/view/238

TY  - JOUR
AU  - Helaly, Areej Mohamed Abdelhady Ahmed
AU  - Amin, Ghada Essam El-Din
AU  - Rahman, Salwa Mostafa Mohammad Abdel
AU  - Allam, Mohamed Farouk
TI  - Role of Ivermectin in Management of COVID-19
T2  - Current Research in Public Health
PY  - 2022
VL  - 2
IS  - 2
SN  - 2831-5162
SP  - 36
EP  - 37
UR  - https://www.scipublications.com/journal/index.php/GJEID/article/view/238
AB  - The pandemic corona virus disease 19 (COVID-19), caused by (SARS-CoV-2) a single stranded-RNA virus, has been spread rapidly worldwide with high rate of morbidity and mortality. Few months after the spread of the pandemic, few medications have proven to be efficient in human clinical trials. Several antiviral drugs have been used outside the scope of their initial medical use, such as lopinavir, hydroxychloroquine or azithromycin. Recent researches were done to show the efficacy of ivermectin in reducing SARS-CoV-2 viral RNA within 2 days. The use of ivermectin in in vitro studies has proven its efficacy against Corona virus. Based on the potency of ivermectin in in vitro studies, various clinical trials including patients infected with COVID-19 have been started; most of them have not been completed yet. Since the way how the virus infects the cells in vitro and in vivo is different, a decisive comment about how the ivermectin could exactly be beneficial to the patients has not been proven yet. Nevertheless, if ivermectin is compared to the other therapeutic treatments available for COVID-19 management, ivermectin has proved to have leverage over them. New randomized controlled clinical trials to assess the effectiveness of ivermectin the management of COVID-19 are strongly and urgently needed.
DO  - Role of Ivermectin in Management of COVID-19
TI  - 10.31586/gjeid.2022.238
ER  -